Somagenetix
Somagenetix is a gene therapy developer for phagocyte disorders founded in 2019 by Ulrich Siler .
1
Funding Rounds
$11.7m
Money raised
Overview
Somagenetix is a gene therapy developer for phagocyte disorders founded in 2019 by Ulrich Siler .
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ul**** Si*** |
|
- | |
| Ja**** Re********* |
|
- |
Funding series
Funding Series Analysis
The company Somagenetix has raised a total of $11.66m in funding over 1 rounds.
Key Insights:
- Somagenetix Series A Round, October 2024: $11.66m
Somagenetix Series A Round, October 2024
$11.66m
Industries
Somagenetix is active in the following industries: